Development of a highly sensitive luciferase assay for intracellular evaluation of coronavirus Mpro activity
COVID-19, caused by SARS-CoV-2 virus, has emerged as a global threat to human health. The main protease (Mpro) of SARS-CoV-2 is an excellent target for the development of antiviral drugs against COVID-19, and various protease biosensors have been developed to evaluate anti-coronavirus drugs. However...
Saved in:
| Main Authors: | Bao Dong, Yuehong Chen, Xin Wang, Jing Li, Sen Zhang, Xiaoping Kang, Yuchang Li, Biao Li, Liangning Liao, Zhengwei Zhang, Jiaqi Xiong, Lele Shao, Shenghai Huang, Ye Feng, Tao Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1560251/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of potential COVID-19 Mpro inhibitors through covalent drug docking, molecular dynamics simulation, and MMGBSA calculation
by: Mohammad Hossein Haghir Ebrahim Abadi, et al.
Published: (2025-07-01) -
Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases
by: Douglas S. Watson, et al.
Published: (2011-08-01) -
Highly efficient discovery of the covalent Mpro inhibitors from crude Pu-erh tea by integrating biochemical and chemoproteomic approaches
by: Guanghao Zhu, et al.
Published: (2025-05-01) -
In Silico Comparison of Main Proteinase Inhibitors for Different Coronaviruses
by: Tahani W. Jihad, et al.
Published: (2024-08-01) -
Purification and Characterization of protease from Zahdi dates plam seeds (Phoenix dactylifera L.)
by: Baghdad Science Journal
Published: (2009-12-01)